Trust linked to Astera Labs CEO sells 139,951 shares
Astera Labs, Inc.’s CEO Mohan Jitendra reported multiple open-market sales of Common Stock on May 7, 2026, totaling 139,951 shares.
Rhea-AI Filing Summary
Astera Labs, Inc.’s CEO Mohan Jitendra reported multiple open-market sales of Common Stock on May 7, 2026, totaling 139,951 shares. The transactions were executed by a living trust associated with him under a pre-arranged Rule 10b5-1 trading plan adopted on December 1, 2025.
Sale prices ranged around $199–$206 per share, reported as weighted averages across several trades. After these sales, the living trust still held 3,929,183 shares of Astera Labs Common Stock, while Jitendra also held additional shares directly and through several estate planning trusts.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 139,951 shares
Net Sell
13 txns
Insider
Mohan Jitendra
Role
Chief Executive Officer
Sold
139,951 shs ($28.01M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 79,377 | $199.3269 | $15.82M |
| Sale | Common Stock | 34,234 | $200.5254 | $6.86M |
| Sale | Common Stock | 14,875 | $201.3982 | $3.00M |
| Sale | Common Stock | 6,048 | $202.5059 | $1.22M |
| Sale | Common Stock | 3,146 | $203.4479 | $640K |
| Sale | Common Stock | 1,311 | $204.7172 | $268K |
| Sale | Common Stock | 960 | $205.7363 | $198K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 3,929,183 shares (Indirect, By Living Trust);
Common Stock — 699,999 shares (Indirect, By Trust);
Common Stock — 700,000 shares (Indirect, By 2021 Trust 1);
Common Stock — 700,000 shares (Indirect, By 2021 Trust 2);
Common Stock — 450,001 shares (Indirect, By 2022 Trust 1);
Common Stock — 450,001 shares (Indirect, By 2022 Trust 2);
Common Stock — 1,452,739 shares (Direct)
Footnotes (14)
- F1. The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025.
- F2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $199.0000 to $199.9900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- F4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $200.0000 to $200.9900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $201.0000 to $201.9900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F6. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $202.1000 to $203.0600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F7. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $203.1800 to $204.1200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F8. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $204.3900 to $205.3450, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F9. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $205.3900 to $205.9700, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F10. These shares are owned directly by an estate planning trust (the "Trust"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- F11. These shares are owned directly by an estate planning trust (the "2021 Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- F12. These shares are owned directly by an estate planning trust (the "2021 Trust 2"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- F13. These shares are owned directly by an estate planning trust (the "2022 Trust 1"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- F14. These shares are owned directly by an estate planning trust (the "2022 Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Key Figures
Shares sold: 139,951 shares
Sale price example: $199.3269 per share
Highest reported average price: $205.7363 per share
+5 more
8 metrics
Shares sold
139,951 shares
Total net shares sold in open-market transactions on May 7, 2026
Sale price example
$199.3269 per share
One reported weighted average sale price for a 79,377-share block
Highest reported average price
$205.7363 per share
Weighted average price for a 960-share sale block
Living trust holdings after sales
3,989,757 shares
Common Stock held by a living trust associated with the CEO after transactions
Direct CEO holdings
1,452,739 shares
Common Stock held directly by Mohan Jitendra after transactions
2021 Trust 1 holdings
700,000 shares
Common Stock held indirectly through 2021 Trust 1
2022 Trust 1 holdings
450,001 shares
Common Stock held indirectly through 2022 Trust 1
Estate planning trust holdings
699,999 shares
Common Stock held indirectly through an estate planning trust labeled "By Trust"
Key Terms
Rule 10b5-1 trading plan, weighted average price, estate planning trust, beneficial ownership, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person..."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions..."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
estate planning trust financial
"These shares are owned directly by an estate planning trust (the "Trust"). The Reporting Person disclaims beneficial ownership..."
beneficial ownership regulatory
"The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein..."
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
pecuniary interest financial
"The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein..."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Astera Labs (ALAB) disclose for its CEO?
Astera Labs disclosed that a living trust associated with CEO Mohan Jitendra sold 139,951 shares of Common Stock. These open-market sales were executed on May 7, 2026 under a pre-arranged Rule 10b5-1 trading plan adopted on December 1, 2025.
Were the Astera Labs (ALAB) insider sales part of a Rule 10b5-1 plan?
Yes. The filing states the sales occurred automatically under a Rule 10b5-1 trading plan adopted on December 1, 2025. Such plans pre-schedule trades, indicating these transactions were structured in advance rather than timed discretionarily by the reporting person.
AI-generated analysis. How Rhea-AI works. Not financial advice.
